Clinical trial
A Multicenter Clinical Study of Romiplostim N01 in the Treatment of Sepsis-related Thrombocytopenia
NCT07595133 is registered in ClinicalTrials.gov with Shanghai 10th People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Clinical Study of Romiplostim N01 in the Treatment of Sepsis-related Thrombocytopenia
- Lead sponsor
- Shanghai 10th People's Hospital
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- June 1, 2026
- Completion date
- December 31, 2027
- Enrollment
- 280 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.